Literature DB >> 22233787

Concurrent validity of an OMNI rating of perceived exertion scale for bench stepping exercise.

Maressa P Krause1, Fredric L Goss, Robert J Robertson, Kevin Kim, Hassan M Elsangedy, Kleverton Krinski, Sergio G da Silva.   

Abstract

To develop and validate a modified OMNI rating of perceived exertion (RPE) scale for use during bench stepping exercise (OMNI-BS). Thirty women (age: 19.8 ± 1.8 years) undertook 2 experimental trials, separated by 7 days. Concurrent validity was established by examining the relation between physiological criterion variables, oxygen consumption (VO2), and heart rate (HR), with the concurrent variable, RPE from OMNI-BS, during 2 trials in which the intensity increased linearly (test 1) and intermittently (test 2). The first test consisted of 3-minute stages. Subjects stepped up and down on the bench at 120 b·min(-1). The test was terminated owing to subject fatigue. Exercise intensity increased as bench height increased every 3 minutes. The second test consisted of three 3-minute exercise bouts that reproduced exercise stage 1 (low intensity), stage 3 (moderate intensity), and stage 5 (high intensity) performed in the first test. The order of these 3 exercise bouts was counterbalanced. Intraclass correlation analysis from experimental trials indicated a strong positive association between RPE and VO2 (r = 0.96 and r = 0.95) and HR (r = 0.95 and r = 0.95). Concurrent validity for the OMNI-BS RPE scale was established for women performing bench stepping exercise.

Entities:  

Mesh:

Year:  2012        PMID: 22233787     DOI: 10.1519/JSC.0b013e318220df8e

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  1 in total

1.  Cross-validation of Peak Oxygen Consumption Prediction Models From OMNI Perceived Exertion.

Authors:  R J Mays; F L Goss; E F Nagle; M Gallagher; L Haile; M A Schafer; K H Kim; R J Robertson
Journal:  Int J Sports Med       Date:  2016-07-13       Impact factor: 3.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.